Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Michel

Showing results (11-20 of 192) with videos related to

Pageof 20
Sort By:
The Journal of Clinical Investigation|November 21, 2001
More sweetness than light? A search for the causes of diabetic vasculopathyJ Igarashi, T Michel
Journal of Cardiovascular Pharmacology|January 1, 1992
Molecular cloning of constitutive endothelial nitric oxide synthase: evidence for a family of related genesT Michel, S Lamas
The Journal of Biological Chemistry|July 27, 2001
Sphingosine 1-phosphate and isoform-specific activation of phosphoinositide 3-kinase beta. Evidence for divergence and convergence of receptor-regulated endothelial nitric-oxide synthase signaling pathwaysJ Igarashi, T Michel
The Journal of Biological Chemistry|October 7, 1994
Endothelial nitric oxide synthase membrane targeting. Evidence against involvement of a specific myristate receptorL Busconi, T Michel
Life Sciences|January 1, 1995
Expression of constitutive endothelial nitric oxide synthase in human blood plateletsK Sase, T Michel
Die Medizinische Welt|March 25, 1983
[Important "reference conditions" in the interpretation of hormone receptor findings in human breast carcinomas. Studies of the nude mouse model]R T Michel, G Bastert
The Journal of Clinical Investigation|October 1, 1983
Plasma membrane receptorsR J Lefkowitz, T Michel
The Journal of Biological Chemistry|November 25, 1982
Hormonal inhibition of adenylate cyclase. alpha 2 Adrenergic receptors promote release of [3H]guanylylimidodiphosphate from platelet membranesT Michel, R J Lefkowitz
FEBS Letters|April 1, 1997
The role of palmitoyl-protein thioesterase in the palmitoylation of endothelial nitric oxide synthaseJ B Michel, T Michel
Die Medizinische Welt|March 25, 1983
[High-dose gestagen therapy with medroxyprogesterone acetate in metastasizing breast carcinoma]G Bastert, R T Michel
Pageof 20

Showing results (11-20 of 192) with videos related to

Sort By:
Pageof 20
The Journal of Clinical Investigation|November 21, 2001
More sweetness than light? A search for the causes of diabetic vasculopathyJ Igarashi, T Michel
Journal of Cardiovascular Pharmacology|January 1, 1992
Molecular cloning of constitutive endothelial nitric oxide synthase: evidence for a family of related genesT Michel, S Lamas
The Journal of Biological Chemistry|July 27, 2001
Sphingosine 1-phosphate and isoform-specific activation of phosphoinositide 3-kinase beta. Evidence for divergence and convergence of receptor-regulated endothelial nitric-oxide synthase signaling pathwaysJ Igarashi, T Michel
The Journal of Biological Chemistry|October 7, 1994
Endothelial nitric oxide synthase membrane targeting. Evidence against involvement of a specific myristate receptorL Busconi, T Michel
Life Sciences|January 1, 1995
Expression of constitutive endothelial nitric oxide synthase in human blood plateletsK Sase, T Michel
Die Medizinische Welt|March 25, 1983
[Important "reference conditions" in the interpretation of hormone receptor findings in human breast carcinomas. Studies of the nude mouse model]R T Michel, G Bastert
The Journal of Clinical Investigation|October 1, 1983
Plasma membrane receptorsR J Lefkowitz, T Michel
The Journal of Biological Chemistry|November 25, 1982
Hormonal inhibition of adenylate cyclase. alpha 2 Adrenergic receptors promote release of [3H]guanylylimidodiphosphate from platelet membranesT Michel, R J Lefkowitz
FEBS Letters|April 1, 1997
The role of palmitoyl-protein thioesterase in the palmitoylation of endothelial nitric oxide synthaseJ B Michel, T Michel
Die Medizinische Welt|March 25, 1983
[High-dose gestagen therapy with medroxyprogesterone acetate in metastasizing breast carcinoma]G Bastert, R T Michel
Pageof 20